Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02273739
Title Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Agios Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Los Angeles California 90095 United States Details
Los Angeles California 91010 United States Details
Miami Florida 33136 United States Details
Baltimore Maryland 21287 United States Details
Boston Massachusetts 02114 United States Details
Omaha Nebraska 68198 United States Details
New York New York 10065 United States Details
Cleveland Ohio 44195 United States Details
Nashville Tennessee 37203 United States Details
Dallas Texas 75390 United States Details
Bordeaux 61283 33076 France Details
Villejuif Cedex 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field